1. Patients ≥18 years on chronic dialysis due to end-stage renal disease. 2. Competence to understand the study rationale, including potential risks and benefits associated with treatment, necessary for written informed consent.

1. Patients ≥18 years on chronic dialysis due to end-stage renal disease. 2. Competence to understand the study rationale, including potential risks and benefits associated with treatment, necessary for written informed consent.